In vitro assays of allosensitization

Area of Science:

• Immunology
• Transplantation Science
• Clinical Assays

Background:

• Current immunosuppression management is reactive, lacking predictive accuracy for organ allograft acceptance.
• Inability to predict recipient immune response necessitates reactive rather than proactive management strategies.
• Existing methods fail to provide early detection of allograft rejection, leading to potential organ damage.

Purpose of the Study:

• To review in vitro assays assessing T cell reactivity to allo-antigens.
• To highlight the need for reliable, non-invasive assays for monitoring immune responses post-transplant.
• To explore how such assays can improve allograft management and patient outcomes.

Main Methods:

• Review of current literature on in vitro T cell-based assays.
• Focus on assays measuring allo-antigen-specific T cell responses.
• Summarization of assays reflecting donor-specific immune responsiveness or non-responsiveness.

Main Results:

• Discusses the potential of in vitro assays for early detection of allograft rejection.
• Highlights the role of assays in enabling personalized immunosuppressive drug therapy.
• Explains how identifying operational tolerance through assays could lead to drug cessation.

Conclusions:

• Simple, reliable, non-invasive assays are needed to predict immune responses to organ allografts.
• These assays can facilitate early intervention, personalized immunosuppression, and potentially drug cessation.
• T cell reactivity assays offer a promising avenue for proactive allograft management.